Toll Free: 1-888-928-9744
Published: Jun, 2014 | Pages:
24 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
Vakzine Projekt Management GmbH - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'Vakzine Projekt Management GmbH - Product Pipeline Review - 2014', provides an overview of the Vakzine Projekt Management GmbH's pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Vakzine Projekt Management GmbH's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Vakzine Projekt Management GmbH including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Vakzine Projekt Management GmbH's human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Vakzine Projekt Management GmbH's pipeline products Reasons to buy - Evaluate Vakzine Projekt Management GmbH's strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Vakzine Projekt Management GmbH in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Vakzine Projekt Management GmbH's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Vakzine Projekt Management GmbH and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Vakzine Projekt Management GmbH - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Vakzine Projekt Management GmbH and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 3 List of Figures 3 Vakzine Projekt Management GmbH Snapshot 4 Vakzine Projekt Management GmbH Overview 4 Key Information 4 Key Facts 4 Vakzine Projekt Management GmbH - Research and Development Overview 5 Key Therapeutic Areas 5 Vakzine Projekt Management GmbH - Pipeline Review 7 Pipeline Products by Stage of Development 7 Pipeline Products - Monotherapy 8 Pipeline Products - Out-Licensed Products 9 Out-Licensed Products/Combination Treatment Modalities 10 Vakzine Projekt Management GmbH - Pipeline Products Glance 11 Vakzine Projekt Management GmbH - Clinical Stage Pipeline Products 11 Phase II Products/Combination Treatment Modalities 11 Vakzine Projekt Management GmbH - Early Stage Pipeline Products 12 Preclinical Products/Combination Treatment Modalities 12 Vakzine Projekt Management GmbH - Drug Profiles 13 VPM-1002 13 Product Description 13 Mechanism of Action 13 R&D Progress 13 VPM-2001 14 Product Description 14 Mechanism of Action 14 R&D Progress 14 VPM-5001 15 Product Description 15 Mechanism of Action 15 R&D Progress 15 Vakzine Projekt Management GmbH - Pipeline Analysis 16 Vakzine Projekt Management GmbH - Pipeline Products by Target 16 Vakzine Projekt Management GmbH - Pipeline Products by Route of Administration 17 Vakzine Projekt Management GmbH - Pipeline Products by Molecule Type 18 Vakzine Projekt Management GmbH - Pipeline Products by Mechanism of Action 19 Vakzine Projekt Management GmbH - Recent Pipeline Updates 20 Vakzine Projekt Management GmbH - Dormant Projects 21 Vakzine Projekt Management GmbH - Locations And Subsidiaries 22 Head Office 22 Appendix 23 Methodology 23 Coverage 23 Secondary Research 23 Primary Research 23 Expert Panel Validation 23 Contact Us 24 Disclaimer 24
List of Tables Vakzine Projekt Management GmbH, Key Information 4 Vakzine Projekt Management GmbH, Key Facts 4 Vakzine Projekt Management GmbH - Pipeline by Indication, 2014 6 Vakzine Projekt Management GmbH - Pipeline by Stage of Development, 2014 7 Vakzine Projekt Management GmbH - Monotherapy Products in Pipeline, 2014 8 Vakzine Projekt Management GmbH - Out-Licensed Products in Pipeline, 2014 9 Vakzine Projekt Management GmbH - Out-Licensed Products/ Combination Treatment Modalities, 2014 10 Vakzine Projekt Management GmbH - Phase II, 2014 11 Vakzine Projekt Management GmbH - Preclinical, 2014 12 Vakzine Projekt Management GmbH - Pipeline by Target, 2014 16 Vakzine Projekt Management GmbH - Pipeline by Route of Administration, 2014 17 Vakzine Projekt Management GmbH - Pipeline by Molecule Type, 2014 18 Vakzine Projekt Management GmbH - Pipeline Products by Mechanism of Action, 2014 19 Vakzine Projekt Management GmbH - Recent Pipeline Updates, 2014 20 Vakzine Projekt Management GmbH - Dormant Developmental Projects,2014 21
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.